GENOCEA BIOSCIENCES, INC.
DelistedCIK 1457612fmd_00K9VPVFMS26TJB55Z56EDV0YJManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2012 to Mar 31, 2022, 38 periods
| Line item | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | – | – | – | – | – | – | – | 0 | 1 | 2 |
| Research and development | 11 | 16 | 24 | 28 | 35 | 39 | 25 | 27 | 34 | 39 |
| Total operating expenses | 15 | 21 | 33 | 42 | 48 | 55 | 40 | 39 | 48 | 54 |
| Operating income | (13) | (20) | (33) | (41) | (48) | (55) | (40) | (39) | (47) | (52) |
| Interest expense | – | – | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 |
| Interest and investment income | – | 0 | 0 | 0 | 0 | 0 | – | – | – | – |
| Other non-operating income (expense) | (0) | (1) | (2) | (1) | (1) | (1) | 12 | 0 | 3 | 19 |
| Net income | (13) | (21) | (35) | (42) | (50) | (57) | (28) | (39) | (44) | (33) |
| Net income to common shareholders | (15) | (22) | (35) | (42) | (50) | – | – | (39) | (52) | (33) |